Mycobacterium avium subspecies paratuberculosis (MAP) and Crohn’s disease: the debate continues
Authors:
Open Access
- 1 July 2023
- journal article
- review article
- Published by AME Publishing Company in Translational Gastroenterology and Hepatology
- Vol. 8, 28
Abstract
Crohn’s disease (CD) in humans and Johne’s disease (JD) in ruminants share numerous clinical and pathologic similarities. As Mycobacteria avium subspecies paratuberculosis (MAP) is known to fulfill Koch’s postulates as the cause of JD, there has been considerable debate over the past century about whether MAP also plays a role in CD. With recent advances in MAP identification techniques, we can now demonstrate a higher presence of MAP in CD patients compared to the general population. However, it remains unclear if MAP is playing a bystander role or is directly pathogenic in these patients. Studies have shown that there may be an immune response targeting MAP in these patients, which may underlie a pathologic role in CD. Clinical studies have yielded conflicting results as to whether anti-MAP therapy improves clinical outcomes in CD, leading to the lack of its inclusion within evidence-based clinical guidelines. Additionally, many of these studies have been small case series, with only a few randomized controlled trials published to date. In this article, we will discuss the historical context of MAP in CD, review clinical and laboratory data surrounding detection of MAP and possible pathogenesis in human disease, and suggest future directions which may finally provide some clarity to this debate.Keywords
This publication has 47 references indexed in Scilit:
- Isolation of Mycobacterium avium Subspecies paratuberculosis Reactive CD4 T Cells from Intestinal Biopsies of Crohn's Disease PatientsPLOS ONE, 2009
- Association between Mycobacterium avium subsp. paratuberculosis DNA in blood and cellular and humoral immune response in inflammatory bowel disease patients and controlsInternational Journal of Infectious Diseases, 2009
- On the Action of Cyclosporine A, Rapamycin and Tacrolimus on M. avium Including Subspecies paratuberculosisPLOS ONE, 2008
- Thiopurine Drugs Azathioprine and 6-Mercaptopurine Inhibit Mycobacterium paratuberculosis Growth In VitroAntimicrobial Agents and Chemotherapy, 2008
- A Novel Multi-Antigen Virally Vectored Vaccine against Mycobacterium avium Subspecies paratuberculosisPLOS ONE, 2007
- Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2007
- On the Action of 5-Amino-Salicylic Acid and Sulfapyridine on M. avium including Subspecies paratuberculosisPLOS ONE, 2007
- Open label trial of oral clarithromycin in active Crohn’s diseaseAlimentary Pharmacology & Therapeutics, 2000
- Controlled trial of antimycobacterial therapy in Crohn's diseaseDigestive Diseases and Sciences, 1991
- Experimental disease in infant goats induced by aMycobacterium isolated from a patient with Crohn's diseaseDigestive Diseases and Sciences, 1986